China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Communicate openly about AI initiatives and their intended impact Acknowledge uncertainties and address concerns proactively Involve employees in AI experiments and decision-making Demonstrate how AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results